![Andrea Sáez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea Sáez
Corporate Officer/Principal at
AGOMAB THERAPEUTICS NV
Net worth: - $ as of 2026-05-30
Profile
Andrea Sáez is currently Chief Development Officer at AgomAb Therapeutics NV since 2023.
Formerly, Dr. Sáez was Chief Operating & Scientific Officer at Origo Biopharma SL from 2020 to 2022, Director-Research & Development at Pangaea Oncology SA from 2015 to 2018, and Manager-Scientific & Regulatory Affairs at Asphalion SL from 2012 to 2015.
Dr. Sáez earned a doctorate from Universitat Pompeu Fabra.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-17 | 0 ( -.--% ) | - $ | 2026-05-30 |
Andrea Sáez active positions
| Companies | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Corporate Officer/Principal | 2021-12-31 |
Former positions of Andrea Sáez
| Companies | Position | End |
|---|---|---|
Origo Biopharma SL
 Origo Biopharma SL BiotechnologyHealth Technology Engages in research and development of immunotherapeutic products which are focused on treating health disorders | Chief Operating Officer | 2021-12-31 |
| PANGAEA ONCOLOGY, S.A. | Chief Tech/Sci/R&D Officer | 2018-08-31 |
Asphalion SL
 Asphalion SL Miscellaneous Commercial ServicesCommercial Services Provides scientific and regulatory affairs consulting services | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Training of Andrea Sáez
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Universitat Pompeu Fabra
 Universitat Pompeu Fabra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pangaea Oncology SA
 Pangaea Oncology SA Medical SpecialtiesHealth Technology Provides molecular diagnostics for cancer treatment | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Engages in research and development of immunotherapeutic products which are focused on treating health disorders | Health Technology |
Asphalion SL
Asphalion SL Miscellaneous Commercial ServicesCommercial Services Provides scientific and regulatory affairs consulting services | Commercial Services |
- Stock Market
- Insiders
- Andrea Sáez
